Please use a PC Browser to access Register-Tadawul
Decoding Hims & Hers Health's Options Activity: What's the Big Picture?
Hims & Hers Health, Inc. Class A HIMS | 15.74 | -0.88% |
Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health (NYSE:HIMS) revealed 16 unusual trades.
Delving into the details, we found 31% of traders were bullish, while 31% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $282,040, and 11 were calls, valued at $560,440.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $3.0 to $50.0 for Hims & Hers Health over the recent three months.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Hims & Hers Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Hims & Hers Health's significant trades, within a strike price range of $3.0 to $50.0, over the past month.
Hims & Hers Health Call and Put Volume: 30-Day Overview

Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | CALL | TRADE | BULLISH | 04/17/26 | $3.8 | $3.45 | $3.8 | $18.00 | $76.7K | 362 | 1 |
| HIMS | CALL | TRADE | NEUTRAL | 01/15/27 | $16.4 | $15.9 | $16.17 | $3.00 | $64.6K | 6.5K | 373 |
| HIMS | PUT | TRADE | BEARISH | 01/15/27 | $20.5 | $20.5 | $20.5 | $37.00 | $57.4K | 855 | 28 |
| HIMS | PUT | TRADE | BEARISH | 01/15/27 | $20.4 | $20.4 | $20.4 | $37.00 | $57.1K | 855 | 165 |
| HIMS | PUT | TRADE | BEARISH | 01/15/27 | $20.55 | $20.05 | $20.4 | $37.00 | $57.1K | 855 | 84 |
About Hims & Hers Health
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
After a thorough review of the options trading surrounding Hims & Hers Health, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of Hims & Hers Health
- Currently trading with a volume of 6,615,978, the HIMS's price is down by -1.94%, now at $18.95.
- RSI readings suggest the stock is currently may be oversold.
- Anticipated earnings release is in 13 days.
What Analysts Are Saying About Hims & Hers Health
5 market experts have recently issued ratings for this stock, with a consensus target price of $30.1.
- An analyst from Citigroup has decided to maintain their Sell rating on Hims & Hers Health, which currently sits at a price target of $16.
- Reflecting concerns, an analyst from Evercore ISI Group lowers its rating to In-Line with a new price target of $33.
- Consistent in their evaluation, an analyst from TD Cowen keeps a Hold rating on Hims & Hers Health with a target price of $20.
- An analyst from BTIG persists with their Buy rating on Hims & Hers Health, maintaining a target price of $60.
- Maintaining their stance, an analyst from B of A Securities continues to hold a Underperform rating for Hims & Hers Health, targeting a price of $21.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.


